Augmentin 1: Early Ruling Favors Generics
February 21, 2002 Introduction. Augmentin (an oral, anti-bacterial drug) is a combination of amoxicillin and potassium clavulnate (a beta-lactamase inhibitor). [...]
Augmentin 2: Federal Trial Judge splits decision
March 1, 2002 GlaxoSmithKline announced that a federal judge in the United States District Court for the Eastern District of [...]
Paxil 1: Glaxo’s Patents Appear Safe Until at least 2006
January 31, 2002 INTRODUCTION Although there has been one $8 million verdict in a personal injury case involving Paxil, it [...]
Paxil 2: Invalidation of UK patents will not impact US cases
August 14, 2002 Introduction. On July 12, 2002, in a revocation proceeding brought by BASF, the British patent court invalidated [...]
Wellbrutrin: Can Glaxo enjoin Andrx during appeal
A Florida Federal judge today denied Glaxo’s motion for summary judgment and granted Andrx’s motion for summary judgment stating that [...]
Wellbutrin® – Glaxo likely to reverse of Andrx decision
February 4, 2003 INTRODUCTION Andrx’s effort to launch bupropion, a generic version of Wellbutrin (an anti-depressant), is awaiting an appellate [...]
Related Case Type
